Your browser doesn't support javascript.
loading
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
Nathenson, Michael J; Hu, Junxiao; Ratan, Ravin; Somaiah, Neeta; Hsu, Robert; DeMaria, Peter J; Catoe, Heath W; Pang, Angela; Subhawong, Ty K; Amini, Behrang; Sweet, Kevin; Feister, Katharina; Malik, Karan; Jagannathan, Jyothi; Braschi-Amirfarzan, Marta; Sheren, Jamie; Caldas, Yupanqui; Moreno Tellez, Cristiam; Rosenberg, Andrew E; Lazar, Alexander J; Maki, Robert G; Benedetto, Pasquale; Cohen, Jonathan; Trent, Jonathan C; Ravi, Vinod; Patel, Shreyaskumar; Wilky, Breelyn A.
Affiliation
  • Nathenson MJ; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hu J; Department of Biostatistics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hsu R; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • DeMaria PJ; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • Catoe HW; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • Pang A; Department of Medicine, Mount Sinai School of Medicine, New York, New York.
  • Subhawong TK; Department of Radiology, University of Miami School of Medicine, Miami, Florida.
  • Amini B; Department of Musculoskeletal Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sweet K; Department of Radiology, University of Miami School of Medicine, Miami, Florida.
  • Feister K; Department of Radiology, University of Miami School of Medicine, Miami, Florida.
  • Malik K; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jagannathan J; Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Braschi-Amirfarzan M; Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sheren J; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado.
  • Caldas Y; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Moreno Tellez C; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Rosenberg AE; Department of Pathology, University of Miami School of Medicine, Miami, Florida.
  • Lazar AJ; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maki RG; Department of Medicine, Mount Sinai School of Medicine, New York, New York.
  • Benedetto P; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • Cohen J; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • Trent JC; Department of Medicine, University of Miami School of Medicine, Miami, Florida.
  • Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wilky BA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Clin Cancer Res ; 28(18): 4092-4104, 2022 09 15.
Article in En | MEDLINE | ID: mdl-35180772
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fibromatosis, Aggressive Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: United States